Fernando Martínez‐Sagasti

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

Bruno François, Simon Lambden, Tom Fivez et al. · The Lancet Respiratory Medicine · 2023 · 60 citations · Full text

Phase 2B, Clinical Trials, Prospective Evaluation +7

Preliminary experience on the safety and tolerability of mechanical “insufflation-exsufflation” in subjects with artificial airway

Miguel Sánchez García, Passio Santos, Gema Rodríguez-Trigo et al. · Intensive Care Medicine Experimental · 2018 · 38 citations · Full text

Big data and machine learning in critical care: Opportunities for collaborative research

Antonio Núñez Reiz, Fernando Martínez‐Sagasti, Manuel Álvarez González et al. · Medicina Intensiva · 2018 · 35 citations

Engineering, Machine Learning, Data Science +9

Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients

Bárbara Balandín, D. Ballesteros, Rafael Ruiz de Luna et al. · International Journal of Antimicrobial Agents · 2021 · 30 citations

Critical Care Medicine, Ill Patients, Antimicrobial Susceptibility +9

Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients

Bárbara Balandín, D. Ballesteros, Vicente Pintado et al. · International Journal of Antimicrobial Agents · 2022 · 24 citations

Ill Patients, Bacterial Infections, Antibiotics +11